Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

General Counsel

See Remarks

Chief Financial Officer

Chief Executive Officer

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, Viral Clearance Prediction kits, and custom services. It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-30	Premium	acquired	Premium	Premium	Premium	General Counsel
2024-04-30	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-04-30	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-04-30	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-04-30	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-04-15	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	General Counsel
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-03-15	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	General Counsel
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-01-16	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-16	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-16	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-01-16	Premium	acquired	Premium	Premium	Premium	General Counsel
2024-01-16	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-16	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-16	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-16	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-11-15	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks

MRVI - Maravai LifeSciences Holdings Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for MRVI